Peer Review in Pharmacovigilance: Lens on Disproportionality Analysis Emanuel RaschiFrancesco SalvoCharles Khouri Editorial 18 March 2024 Pages: 601 - 605
Lessons Learned on Observed-to-Expected Analysis Using Spontaneous Reports During Mass Vaccination María Gordillo-MarañónGianmario CandoreXavier Kurz Current Opinion Open access 09 April 2024 Pages: 607 - 615
Enzalutamide: Understanding and Managing Drug Interactions to Improve Patient Safety and Drug Efficacy Brandon W. LennepJesse MackAlicia K. Morgans Review Article Open access 12 April 2024 Pages: 617 - 641
The Role of Mitochondria in Statin-Induced Myopathy Gavin BellAnastasia ThomaAdam P. Lightfoot Review Article 16 March 2024 Pages: 643 - 653
The Reporting Recommendations Intended for Pharmaceutical Risk Minimization Evaluation Studies: Standards for Reporting of Implementation Studies Extension (RIMES-SE) Meredith Y. SmithElaine H. MorratoAlmut G. Winterstein Original Research Article Open access 13 March 2024 Pages: 655 - 671
Angiotensin Receptor Blockers and the Risk of Suspected Drug-Induced Liver Injury: A Retrospective Cohort Study Using Electronic Health Record-Based Common Data Model in South Korea Hyunjoo KimNayeong SonEunkyung Euni Lee Original Research Article Open access 21 March 2024 Pages: 673 - 686
Fatal Intoxications with Zopiclone—A Cause for Concern? Lova TrallaSara GustavssonFredrik C. Kugelberg Original Research Article Open access 27 March 2024 Pages: 687 - 697
Composite Plot for Visualizing Aminotransferase and Bilirubin Changes in Clinical Trials of Subjects with Abnormal Baseline Values Bereket TesfaldetTejas PatelEileen Navarro Almario Original Research Article Open access 20 April 2024 Pages: 699 - 710
The Safety of Ixekizumab in Chinese Adults with Moderate-to-Severe Plaque Psoriasis: Analyses from a Prospective, Single-Arm, Multicenter, 12-Week Observational Study Ying LiLin DangYuling Shi Original Research Article Open access 30 April 2024 Pages: 711 - 719